文献速递系统性红斑狼疮

多层全基因组关联研究后分析流程定义系统性红斑狼疮的功能变异与靶基因

A Multilayered Post-Genome-Wide Association Study Analysis Pipeline Defines Functional Variants and Target Genes for Systemic Lupus Erythematosus.
PubMed 文献 · Arthritis Rheumatol · 2024-03-26

该研究利用生物信息学、分子建模及整合功能基因组与表观基因组分析优化精细定位,以452个索引SNP为锚定筛选9,931个高连锁不平衡SNP并定义182个非HLA独立SLE位点。143个位点的3,746个SNP调控564个独特基因,其中329个SNP(106个位点)显示显著等位基因特异性染色质可及性和/或增强子活性。CRISPR/Cas9验证rs57668933为调控包括SLE风险基因ELF1在内的多靶点功能变异。

要点

  • 以452个索引SNP为锚定,筛选9,931个高连锁不平衡(r2>0.8)SNP,定义182个非HLA独立SLE位点。
  • 143个位点的3,746个SNP调控564个独特基因,靶基因富集于狼疮相关组织并与其他自身免疫病相关。
  • 329个SNP(106个位点)显示显著等位基因特异性染色质可及性和/或增强子活性,提示调控潜力。

核心结论

  • 研究展示并验证了利用多维数据优先筛选SLE发病机制中可能因果变异及其同源靶基因的全基因组关联研究后策略,提供显著SLE相关SNP、位点、靶基因及可能生化机制目录以指导实验表征。

研究设计与样本

  • 全基因组关联研究后综合分析,采用广泛生物信息学、分子建模及整合功能基因组与表观基因组分析优化精细定位。
  • 汇编并交叉引用免疫细胞特异性表达数量性状位点(顺式和反式)与启动子捕获高通量捕获染色质构象、等位基因特异性染色质可及性及大规模平行报告基因测定数据。
  • 以452个索引SNP为锚定,筛选9,931个高连锁不平衡(r2>0.8)SNP,定义182个独立非人类白细胞抗原(HLA)SLE位点。
  • 利用CRISPR/Cas9基因组编辑、定量聚合酶链反应和蛋白质印迹实验验证预测位点。

主要发现

  • 143个位点的3,746个SNP被鉴定调控564个独特基因,靶基因富集于狼疮相关组织并与其他自身免疫病相关。
  • 329个SNP(106个位点)显示显著等位基因特异性染色质可及性和/或增强子活性,提示调控潜力。
  • 使用CRISPR/Cas9验证参考SNP标识符57668933(rs57668933)为功能变异,调控包括B细胞中SLE风险基因ELF1在内的多个靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Systemic lupus erythematosus (SLE), an autoimmune disease with incompletely understood etiology, has a strong genetic component. Although genome-wide association studies (GWASs) have revealed multiple SLE susceptibility loci and associated single-nucleotide polymorphisms (SNPs), the precise causal variants, target genes, cell types, tissues, and mechanisms of action remain largely unknown. METHODS: Here, we report a comprehensive post-GWAS analysis using extensive bioinformatics, molecular modeling, and integrative functional genomic and epigenomic analyses to optimize fine-mapping. We compile and cross-reference immune cell-specific expression quantitative trait loci (cis- and trans-expression quantitative trait loci) with promoter capture high-throughput capture chromatin conformation (PCHi-C), allele-specific chromatin accessibility, and massively parallel reporter assay data to define predisposing variants and target genes. We experimentally validate a predicted locus using CRISPR/Cas9 genome editing, quantitative polymerase chain reaction, and Western blot. RESULTS: Anchoring on 452 index SNPs, we selected 9,931 high linkage disequilibrium (r2 > 0.8) SNPs and defined 182 independent non-human leukocyte antigen (HLA) SLE loci. The 3,746 SNPs from 143 loci were identified as regulating 564 unique genes. Target genes are enriched in lupus-related tissues and associated with other autoimmune diseases. Of these, 329 SNPs (106 loci) showed significant allele-specific chromatin accessibility and/or enhancer activity, indicating regulatory potential. Using CRISPR/Cas9, we validated reference SNP identifier 57668933 (rs57668933) as a functional variant regulating multiple targets, including SLE-risk gene ELF1 in B cells. CONCLUSION: We demonstrate and validate post-GWAS strategies for using multidimensional data to prioritize likely causal variants with cognate gene targets underlying SLE pathogenesis. Our results provide a catalog of significantly SLE-associated SNPs and loci, target genes, and likely biochemical mechanisms to guide experimental characterization.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Fazel-Najafabadi M, Looger LL, Rallabandi HR, et al. A Multilayered Post-Genome-Wide Association Study Analysis Pipeline Defines Functional Variants and Target Genes for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2024. PMID: 38369936. doi:10.1002/art.42829

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。